{"id":"NCT01436396","sponsor":"Sanofi Pasteur, a Sanofi Company","briefTitle":"Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers","officialTitle":"Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril®) Administered Concomitantly With Tetravalent Dengue Vaccine in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-07","primaryCompletion":"2013-09","completion":"2013-09-02","firstPosted":"2011-09-19","resultsPosted":"2019-07-29","lastUpdate":"2022-03-25"},"enrollment":792,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Dengue","Dengue Hemorrhagic Fever","Yellow Fever"],"interventions":[{"type":"BIOLOGICAL","name":"Live, attenuated dengue serotype 1, 2, 3, and 4 virus","otherNames":["CYD Dengue Vaccine"]},{"type":"BIOLOGICAL","name":"Yellow fever vaccine","otherNames":["Stamaril®"]},{"type":"BIOLOGICAL","name":"Measles, mumps, and rubella (MMR) vaccine","otherNames":["MMR vaccine"]},{"type":"BIOLOGICAL","name":"Pneumococcal Conjugated Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Hepatitis A Pediatric Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine","otherNames":["DTaP IPV//Hib Vaccine"]},{"type":"BIOLOGICAL","name":"Live, attenuated dengue serotype 1, 2, 3, and 4 virus","otherNames":["CYD dengue vaccine"]},{"type":"BIOLOGICAL","name":"Yellow Fever Vaccine","otherNames":["Stamaril®"]},{"type":"BIOLOGICAL","name":"Placebo (NaCl)","otherNames":["NaCl 0.9%"]},{"type":"BIOLOGICAL","name":"Measles, mumps, and rubella vaccine","otherNames":["MMR vaccine"]},{"type":"BIOLOGICAL","name":"Pneumococcal Conjugated Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine","otherNames":["DTaP IPV//Hib Vaccine"]},{"type":"BIOLOGICAL","name":"Hepatitis A Pediatric Vaccine","otherNames":[]}],"arms":[{"label":"CYD Dengue Vaccine Group","type":"EXPERIMENTAL"},{"label":"Placebo Group","type":"EXPERIMENTAL"}],"summary":"The study was designed to evaluate whether the first CYD dengue vaccination can be administered concomitantly with Stamaril® yellow fever vaccine during the same day and visit, but at 2 different sites of administration.\n\nPrimary Objective:\n\n* To demonstrate the non-inferiority of the immune response against Yellow Fever (YF) in flavivirus (FV) non-immune subjects at baseline receiving one dose of Stamaril vaccine administered concomitantly with the first dose of CYD dengue vaccine compared to participants receiving one dose of Stamaril vaccine concomitantly with placebo.\n\nSecondary Objectives:\n\n* To assess the non-inferiority of YF immune response 28 days post-Stamaril vaccination based on seroconversion rates regardless of the FV status of participants at baseline.\n* To describe the YF immune response 28 days post-Stamaril vaccination in both groups.\n* To describe the antibody (Ab) response to each dengue virus serotype 28 days post CYD dengue vaccine (Visit \\[V\\] 05 and V07), following CYD dengue vaccine Dose 1 and Dose 2 from Group 2 versus following CYD dengue vaccine Dose 2 and Dose 3 for Group 1 (effect of YF vaccination).\n* To describe the safety of Stamaril vaccine administered concomitantly with the first dose of CYD dengue vaccine, or Stamaril administered concomitantly with placebo.\n* To describe the safety of CYD dengue vaccine after the first dose of CYD dengue vaccine administered concomitantly with Stamaril vaccine or CYD vaccine administered alone.\n* To describe the safety of the CYD dengue vaccine in all participants after each dose.","primaryOutcome":{"measure":"Percentage of Flavi Virus (FV) Non-immune Participants With Seroconversion Against YF Antigen After Vaccination With Yellow Fever (YF) Vaccine (Stamaril®) Concomitantly With Either CYD Dengue Vaccine or a Placebo","timeFrame":"28 days Post-Injection 1","effectByArm":[{"arm":"CYD Dengue Vaccine Group","deltaMin":100,"sd":null},{"arm":"Placebo Group","deltaMin":99.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":2,"countries":["Colombia","Peru"]},"refs":{"pmids":[],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":394},"commonTop":["Appetite lost; Post-Any injection","Irritability; Post-Any injection","Crying abnormal; Post-Any injection","Fever; Post-Any Injection","Drowsiness; Post-Any Injection"]}}